We are live on ! Find out more
CALC icon

CalciMedica
CALC

29 hedge funds and large institutions have $15.1M invested in CalciMedica in 2024 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 2

100% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 5

21% more funds holding

Funds holding: 24 → 29 (+5)

11% more capital invested

Capital invested by funds: $13.6M → $15.1M (+$1.54M)

3.14% more ownership

Funds ownership: 28.49% → 31.63% (+3.1%)

Holders
29
Holders Change
+5
Holders Change %
+20.83%
% of All Funds
0.38%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
10
Increased
8
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SCM
Stonepine Capital Management
Oregon
+$1.64M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$1.3M
3
DM
Deerfield Management
New York
+$1.05M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$298K
5
Renaissance Technologies
Renaissance Technologies
New York
+$151K

Top Sellers

1
BCM
BML Capital Management
Indiana
-$682K
2
PAM
PVG Asset Management
Colorado
-$67K
3
First Manhattan
First Manhattan
New York
-$58.6K
4
CCM
Connective Capital Management
California
-$37K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
DM
1
Deerfield Management
New York
$4.6M +$1.05M +300,000 +30%
SCM
2
Soleus Capital Management
Connecticut
$2.78M – – –
ACM
3
Aisling Capital Management
New York
$1.84M – – –
SCM
4
Stonepine Capital Management
Oregon
$1.66M +$1.64M +468,793 New
Alyeska Investment Group
5
Alyeska Investment Group
Illinois
$1.32M +$1.3M +372,256 New
Vanguard Group
6
Vanguard Group
Pennsylvania
$1.2M +$298K +85,000 +33%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$322K +$85.2K +24,313 +37%
Millennium Management
8
Millennium Management
New York
$255K +$59K +16,824 +30%
Envestnet Asset Management
9
Envestnet Asset Management
Illinois
$165K +$10.2K +2,921 +7%
MPM
10
Meritage Portfolio Management
Kansas
$163K – – –
Renaissance Technologies
11
Renaissance Technologies
New York
$153K +$151K +43,200 New
Corient Private Wealth
12
Corient Private Wealth
Florida
$135K +$133K +38,000 New
AI
13
Atria Investments
North Carolina
$120K +$26.3K +7,509 +28%
WIA
14
Wealthedge Investment Advisors
New York
$98.5K +$97.5K +27,819 New
JGC
15
J. Goldman & Co
New York
$66.9K – – –
Cetera Investment Advisers
16
Cetera Investment Advisers
Illinois
$59.7K +$16K +4,566 +37%
BlackRock
17
BlackRock
New York
$56.5K -$414 -118 -0.7%
TW
18
TritonPoint Wealth
Maryland
$53.5K – – –
Bank of America
19
Bank of America
North Carolina
$31.9K -$670 -191 -2%
TRCT
20
Tower Research Capital (TRC)
New York
$6.12K +$4.29K +1,224 New
Osaic Holdings
21
Osaic Holdings
Arizona
$3.43K +$3.39K +968 New
Morgan Stanley
22
Morgan Stanley
New York
$3.03K – – –
Russell Investments Group
23
Russell Investments Group
United Kingdom
$1.77K +$1.75K +500 New
UBS Group
24
UBS Group
Switzerland
$1.15K +$1.09K +310 +2,067%
BBHC
25
Brown Brothers Harriman & Co
New York
$1.09K – – –
1
2

CALC Hedge Fund Activity: Q4 2024 in Review

29 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in CalciMedica (CALC) for Q4 2024, worth a combined $15.1M — up 11% from $13.6M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new CALC positions and 5 closed out — a net gain of 5 holders — while 8 added to existing stakes and 2 trimmed.

The largest buyer was Stonepine Capital Management, opening a new position worth an estimated $1.64M. The largest seller was BML Capital Management, exiting entirely with an estimated $682K sold.

  • 29 institutional investors held CalciMedica (CALC) as of Q4 2024, up from 24 in Q3 2024.
  • Funds reported $15.1M of CalciMedica stock for Q4 2024, up 11% quarter-over-quarter.
  • 10 funds opened new CalciMedica positions in Q4 2024 and 5 closed out, a net change of +5 holders.
  • The largest CalciMedica buyer in Q4 2024 was Stonepine Capital Management, an estimated $1.64M added.
  • The largest CalciMedica seller in Q4 2024 was BML Capital Management, an estimated $682K sold.

Based on aggregated 13F filings for Q4 2024.